Meet Dr. John Rectenwald Vascular Surgeon in Dallas

Vascular surgeon John Rectenwald, M.D., is nationally known for treating patients with peripheral artery disease (PAD) – a condition characterized by a narrowing of the vessels that carry blood to the arms and legs – and for his expertise in the placement and removal of inferior vena cava (IVC) filters.

Dr. Rectenwald sees patients with all types of vascular conditions, and he chose this specialty because he’s able to treat all aspects of vascular disease without needing to send patients to multiple specialists for care.

“Whether they require surgery, medication, or another form of treatment for their vascular disease, as a vascular specialist, I’m able to deliver the care they need,” he says. “Providing comprehensive care for the vascular patient is what makes me happy to come to work every day.”

These solutions for patients may include traditional surgery, endovascular or minimally invasive vascular surgery, balloons or stents to open vessels, or prescribing medications such as those to lower blood pressure or cholesterol or prevent blood clots.

As Chief of the Division of Vascular and Endovascular Surgery at UT Southwestern Medical Center, Dr. Rectenwald is honored to be leading a group with a reputation of clinical excellence and a history of innovation and research in the field of vascular surgery.

He oversees a team of talented vascular surgeons who treat the entire range of vascular conditions, including abdominal aortic aneurysms, peripheral artery disease, carotid artery disease, venous disease, and deep vein thrombosis.

Dr. Rectenwald earned his reputation for expertise in IVC filters – small devices designed to prevent blood clots from traveling to the lungs (known as pulmonary emboli) – and treatment of PAD through years of experience.

“Particularly in patients with PAD, you have to be thoughtful about the care you provide a patient. They are always going to have vascular disease, so you have to be thinking several steps ahead and make sure you don’t do anything in the short term that will eliminate future options for treatment that might harm them in the long run,” he says. “It’s challenging, and that’s another reason I enjoy it.”